Cargando...
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
RATIONALE: There is no consensus as to when treatment for idiopathic pulmonary fibrosis (IPF) should be initiated. Some physicians prefer not to treat patients with preserved lung volume. OBJECTIVE: To investigate whether patients with IPF and preserved lung volume receive the same benefit from nint...
Gardado en:
| Publicado en: | Thorax |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520269/ https://ncbi.nlm.nih.gov/pubmed/27672117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2016-208710 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|